{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:23:44Z","timestamp":1794842624947,"version":"4.9.1"},"reference-count":186,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.05.011","type":"book-chapter","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:55:38Z","timestamp":1779825338000},"page":"397-434","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dysregulation in Alzheimer\u2019s disease: Mechanisms, markers, and therapeutic prospects"],"prefix":"10.1016","author":[{"given":"Radhika","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13041-019-0430-y","article-title":"Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"12","author":"Adav","year":"2019","journal-title":"Molecular Brain"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.14336\/AD.2020.0910","article-title":"Nilotinib improves bioenergetic profiling in brain astroglia in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"12","author":"Adlimoghaddam","year":"2021","journal-title":"Aging and Disease"},{"key":"10.1016\/bs.irn.2026.05.011_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nbd.2019.03.008","article-title":"Regional hypometabolism in the 3xTg mouse model of Alzheimer\u2019s disease","volume":"127","author":"Adlimoghaddam","year":"2019","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2026.05.011_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100400","article-title":"FDG-PET brain glucose hypometabolism predicts Alzheimer\u2019s disease progression pathways in cognitively normal adults: A longitudinal competing risks modeling","volume":"28","author":"Alhasan","year":"2025","journal-title":"Metabolism Open"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70033","article-title":"The role of the urea cycle in the Alzheimer\u2019s disease brain","volume":"169","author":"Al\u2010Thani","year":"2025","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An english translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clinical Anatomy"},{"key":"10.1016\/bs.irn.2026.05.011_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2022.12.016","article-title":"Insulin resistance in Alzheimer\u2019s disease: The genetics and metabolomics links","volume":"539","author":"Amin","year":"2023","journal-title":"Clinica Chimica Acta"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/cells11020214","article-title":"One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration","volume":"11","author":"Lionaki","year":"2022","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.05.011_bib9","doi-asserted-by":"crossref","unstructured":"Andrade, L. J. de O., de Oliveira, L. M., Bittencourt, A. M. V., Louren\u00e7o, L. G. de C., & de Oliveira, G. C. M. (n.d.). Brain insulin resistance and Alzheimer\u2019s disease: A systematic review. Dementia & Neuropsychologia, 18, e20230032. https:\/\/doi.org\/10.1590\/1980\u20135764-DN-2023\u20130032.","DOI":"10.1590\/1980-5764-dn-2023-0032"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib10","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.3390\/ijms15057513","article-title":"The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: Emerging new roles in mitochondrial pathophysiology","volume":"15","author":"Antoniel","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib11","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.2353\/ajpath.2009.090219","article-title":"Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria","volume":"175","author":"Area-Gomez","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.irn.2026.05.011_bib12","doi-asserted-by":"crossref","unstructured":"Badhwar, A., & Haqqani, A. S. (n.d.). Biomarker potential of brain\u2010secreted extracellular vesicles in blood in Alzheimer\u2019s disease. https:\/\/doi.org\/10.1002\/dad2.12001.","DOI":"10.1002\/dad2.12001"},{"key":"10.1016\/bs.irn.2026.05.011_bib13","doi-asserted-by":"crossref","DOI":"10.54844\/mtm.2023.0409","article-title":"Metabolic biomarkers for Alzheimer\u2019s disease: A mini review","volume":"1","author":"Bai","year":"2023","journal-title":"Metabolism and Translational Medicine"},{"key":"10.1016\/bs.irn.2026.05.011_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmic.2025.100154","article-title":"Understanding the interconnected roles of gut microbiota and metabolomic profiles in alcoholic liver disease pathophysiology and their potential for innovative treatment strategies","volume":"26","author":"Balakrishnan","year":"2025","journal-title":"Medicine in Microecology"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: Focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.irn.2026.05.011_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.873301","article-title":"Significance of brain glucose hypometabolism, altered insulin signal transduction, and insulin resistance in several neurological diseases","volume":"13","author":"Bl\u00e1zquez","year":"2022","journal-title":"Frontiers in Endocrinology"},{"issue":"10\u201311","key":"10.1016\/bs.irn.2026.05.011_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.mad.2004.07.009","article-title":"The role of oxidative damage and stress in aging","volume":"125","author":"Bokov","year":"2004","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/bs.irn.2026.05.011_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","article-title":"18F-FDG-PET detects drastic changes in brain metabolism in the Tg4\u201342 model of Alzheimer\u2019s disease","volume":"10","author":"Bouter","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/BST20180025","article-title":"Mitochondrial dysfunction and neurodegenerative proteinopathies: Mechanisms and prospects for therapeutic intervention","volume":"46","author":"Briston","year":"2018","journal-title":"Biochemical Society Transactions"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41398-025-03550-w","article-title":"Fueling the brain\u2014The role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer\u2019s disease","volume":"15","author":"Budny","year":"2025","journal-title":"Translational Psychiatry"},{"key":"10.1016\/bs.irn.2026.05.011_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/509654","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer\u2019s disease","volume":"2015","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160726","article-title":"Mitochondrial aspects of synaptic dysfunction in Alzheimer\u2019s disease","volume":"57","author":"Cai","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1872214810666160615102809","article-title":"Alterations in glucose metabolism in Alzheimer\u2019s disease","volume":"10","author":"Calsolaro","year":"2016","journal-title":"Recent Patents on Endocrine, Metabolic & Immune Drug Discovery"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.irn.2026.05.011_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1430465","article-title":"New insights in lipid metabolism: Potential therapeutic targets for the treatment of Alzheimer\u2019s disease","volume":"18","author":"Cao","year":"2024","journal-title":"Frontiers in Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.011_bib26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2174\/1570159X19666211102150955","article-title":"Lipids as early and minimally invasive biomarkers for Alzheimer\u2019s disease","volume":"20","author":"Casas-Fern\u00e1ndez","year":"2022","journal-title":"Current Neuropharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103039","article-title":"Glutamatergic neurotransmission in aging and neurodegenerative diseases: A potential target to improve cognitive impairment in aging","volume":"55","author":"Castillo-Vazquez","year":"2024","journal-title":"Archives of Medical Research"},{"key":"10.1016\/bs.irn.2026.05.011_bib28","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S. S., Bir, A., Poddar, J., Sinha, M., Ganguly, A., & Chakrabarti, S. (n.d.). Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the Pathogenesis of Alzheimer\u2019s disease. Current Alzheimer Research, 13(11), 1232\u20131248. https:\/\/doi.org\/10.2174\/1567205013666160603004239.","DOI":"10.2174\/1567205013666160603004239"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/alz.12675","article-title":"Predictive metabolic networks reveal sex and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer disease","volume":"19","author":"Chang","year":"2023","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cns.12503","article-title":"Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction","volume":"22","author":"Chao","year":"2016","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13110359","article-title":"Type 3 diabetes: Linking insulin resistance to cognitive decline","volume":"13","author":"Chapple","year":"2025","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib32","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1038\/s41598-018-25968-7","article-title":"Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: A pilot study","volume":"8","author":"Chatterjee","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2026.05.011_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105605","article-title":"Extracellular vesicles: New horizons in neurodegeneration","volume":"113","author":"Chen","year":"2025","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-024-02071-0","article-title":"Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.irn.2026.05.011_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41420-025-02600-y","article-title":"The multifaceted roles of apolipoprotein E4 in Alzheimer\u2019s disease pathology and potential therapeutic strategies","volume":"11","author":"Chen","year":"2025","journal-title":"Cell Death Discovery"},{"key":"10.1016\/bs.irn.2026.05.011_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Progress in Neurobiology"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.011_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/metabo10100384","article-title":"Diverse immunoregulatory roles of Oxysterols\u2014the oxidized cholesterol metabolites","volume":"10","author":"Choi","year":"2020","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib38","first-page":"155","article-title":"Metabolic failure due to thiamine deficiency during critical illness","volume":"27","author":"Cobilinschi","year":"2024","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70294","article-title":"The energetic collapse of the Alzheimer\u2019s brain: Metabolic inflexibility across cells and networks","volume":"169","author":"Constantino","year":"2025","journal-title":"Journal of Neurochemistry"},{"issue":"5123","key":"10.1016\/bs.irn.2026.05.011_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the early detection and progression of Alzheimer\u2019s disease","volume":"14","author":"Counts","year":"2017","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/bs.irn.2026.05.011_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-021-00424-9","article-title":"New approaches to symptomatic treatments for Alzheimer\u2019s disease","volume":"16","author":"Cummings","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"19","key":"10.1016\/bs.irn.2026.05.011_bib43","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2026.05.011_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1471-4159.2001.00285.x","article-title":"N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: Its relevance to studies of acute brain injury","volume":"77","author":"Demougeot","year":"2001","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.011_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13503","article-title":"Effects of cerebral amyloid angiopathy on the brain vasculome","volume":"21","author":"Deng","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/bs.irn.2026.05.011_bib46","doi-asserted-by":"crossref","unstructured":"Dighriri, I. M., Alsubaie, A. M., Hakami, F. M., Hamithi, D. M., Alshekh, M. M., Khobrani, F. A., \u2026\u00a0Tawhari, M. Q. (n.d.). Effects of omega-3 polyunsaturated fatty acids on brain functions: A systematic review. Cureus, 14(10), e30091. https:\/\/doi.org\/10.7759\/cureus.30091.","DOI":"10.7759\/cureus.30091"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079977","article-title":"Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer\u2019s mouse brain: Implication for bioenergetic intervention","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70060","article-title":"The early diagnosis of Alzheimer\u2019s disease: Blood-based panel biomarker discovery by proteomics and metabolomics","volume":"30","author":"Dong","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.011_bib49","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/brain\/awx258","article-title":"PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"140","author":"Du","year":"2017","journal-title":"Brain: A Journal of Neurology"},{"issue":"43","key":"10.1016\/bs.irn.2026.05.011_bib50","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","article-title":"Tau promotes neurodegeneration via DRP1 mislocalization in vivo","volume":"75","author":"DuBoff","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/MNM.0000000000001460","article-title":"Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology","volume":"42","author":"Duong","year":"2021","journal-title":"Nuclear Medicine Communications"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1559325818790158","article-title":"Role of N-acetylcysteine and coenzyme Q10 in the amelioration of myocardial energy expenditure and oxidative stress, induced by carbon tetrachloride intoxication in rats","volume":"16","author":"Elbaky","year":"2018","journal-title":"Dose-Response"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/187152710791556113","article-title":"Oxidative stress and altered mitochondrial function in neurodegenerative diseases: Lessons from mouse models","volume":"9","author":"Fern\u00e1ndez-Checa","year":"2010","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1016\/bs.irn.2026.05.011_bib55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fnins.2018.00830","article-title":"Insulin resistance in Alzheimer\u2019s disease","volume":"12","author":"Ferreira","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"3, ement","key":"10.1016\/bs.irn.2026.05.011_bib56","first-page":"S196","article-title":"The critical need for defining preclinical biomarkers in Alzheimer\u2019s disease","volume":"10","author":"Fiandaca","year":"2014","journal-title":"Alzheimer\u2019s & Dementia, Military Risk Supplement"},{"key":"10.1016\/bs.irn.2026.05.011_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mcn.2019.06.009","article-title":"Mitochondrial dynamics and transport in Alzheimer\u2019s disease","volume":"98","author":"Flannery","year":"2019","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"24","key":"10.1016\/bs.irn.2026.05.011_bib58","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1523\/JNEUROSCI.0116-19.2019","article-title":"PTCD1 is required for mitochondrial oxidative-phosphorylation: Possible genetic association with Alzheimer\u2019s disease","volume":"39","author":"Fleck","year":"2019","journal-title":"The Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib59","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2011.04.023","article-title":"Regional expansion of hypometabolism in Alzheimer\u2019s disease follows amyloid deposition with temporal delay","volume":"71","author":"F\u00f6rster","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1570159X15666170703101816","article-title":"Statins and the brain: More than lipid lowering agents?","volume":"17","author":"Fracassi","year":"2019","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/bs.irn.2026.05.011_bib61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fnins.2019.00629","article-title":"Altered insulin signaling in Alzheimer\u2019s disease brain \u2013 special emphasis on PI3K-Akt pathway","volume":"13","author":"Gabbouj","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.011_bib62","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1007\/s00259-025-07379-9","article-title":"Glucose metabolism in hyper-connected regions predicts neurodegeneration and speed of conversion in Alzheimer\u2019s disease","volume":"52","author":"Galli","year":"2025","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.011_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70519","article-title":"Mitochondrial complex I deficiency induces Alzheimer\u2019s disease-like signatures that are reversible by targeted therapy","volume":"21","author":"Gao","year":"2025","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"key":"10.1016\/bs.irn.2026.05.011_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111077","article-title":"Plasma levels of adipokines and insulin are associated with markers of brain atrophy and cognitive decline in the spectrum of Alzheimer\u2019s Disease","volume":"134","author":"Garcia-Garcia","year":"2024","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/bs.irn.2026.05.011_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1625087","article-title":"Lipid metabolic dysregulation-induced neuroinflammation in the pathophysiology of major depressive disorder","volume":"16","author":"Ge","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.05.011_bib66","doi-asserted-by":"crossref","unstructured":"Geijselaers, S. L. C., Aalten, P., Ramakers, I. H. G. B., De Deyn, P. P., Heijboer, A. C., Koek, H. L., \u2026Biessels, G. J. (n.d.). Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease, 61(1), 309\u2013320. https:\/\/doi.org\/10.3233\/JAD-170522.","DOI":"10.3233\/JAD-170522"},{"key":"10.1016\/bs.irn.2026.05.011_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.ircmb.2018.05.006","article-title":"Mitochondria and reactive oxygen species in aging and age-related diseases","volume":"340","author":"Giorgi","year":"2018","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"22","key":"10.1016\/bs.irn.2026.05.011_bib68","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1111\/bph.14513","article-title":"OSCP subunit of mitochondrial ATP synthase: Role in regulation of enzyme function and of its transition to a pore","volume":"176","author":"Giorgio","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040571","article-title":"Kynurenic acid levels are increased in the CSF of Alzheimer\u2019s disease patients","volume":"10","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/bs.irn.2026.05.011_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100237","article-title":"Repurposing oncology drugs for Alzheimer\u2019s: Multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence","volume":"28","author":"Gopukumar","year":"2025","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/bs.irn.2026.05.011_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.674071","article-title":"Insights into parkin-mediated mitophagy in Alzheimer\u2019s disease: A systematic review","volume":"13","author":"Goudarzi","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.476","article-title":"Cholesterol metabolism: Physiological regulation and diseases","volume":"5","author":"Guo","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/bs.irn.2026.05.011_bib73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s42003-020-1079-x","article-title":"\u03b2-Amyloid and tau drive early Alzheimer\u2019s disease decline while glucose hypometabolism drives late decline","volume":"3","author":"Hammond","year":"2020","journal-title":"Communications Biology"},{"issue":"18","key":"10.1016\/bs.irn.2026.05.011_bib74","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.7150\/thno.59776","article-title":"Alzheimer\u2019s disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib75","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005072-199501000-00005","article-title":"Functional alterations in Alzheimer\u2019s disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone","volume":"54","author":"Harr","year":"1995","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","article-title":"Lipidome disruption in Alzheimer\u2019s disease brain: Detection, pathological mechanisms, and therapeutic implications","volume":"20","author":"He","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1212\/WNL.50.2.380","article-title":"Frontal lobe hypometabolism and depression in Alzheimer\u2019s disease","volume":"50","author":"Hirono","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24709","article-title":"Mitochondrial DNA mutations increase in early stage Alzheimer\u2019s disease and are inconsistent with oxidative damage","volume":"80","author":"Hoekstra","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2026.05.011_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2019.00088","article-title":"Insulin signaling impairment in the brain as a risk factor in Alzheimer\u2019s disease","volume":"11","author":"H\u00f6lscher","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood\u2013brain barrier disruption: Effects and mechanisms","volume":"27","author":"Huang","year":"2020","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/bs.irn.2026.05.011_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2026.05.011_bib84","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/s41467-019-11813-6","article-title":"Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease","volume":"10","author":"Jadiya","year":"2019","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.420","article-title":"Probiotics, prebiotics, and postbiotics in health and disease","volume":"4","author":"Ji","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/bs.irn.2026.05.011_bib86","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000435","article-title":"Disrupted blood-CSF barrier to urea and creatinine in mild cognitive impairment and Alzheimer\u2019s disease","volume":"08","author":"Johansona","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease & Parkinsonism"},{"key":"10.1016\/bs.irn.2026.05.011_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007315","article-title":"Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues","volume":"13","author":"Kakoti","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib88","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1007\/s12035-025-04989-0","article-title":"Ceramides may play a central role in the pathogenesis of Alzheimer\u2019s disease: A review of evidence and horizons for discovery","volume":"62","author":"Kalkman","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib89","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib90","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3349\/ymj.2017.58.3.479","article-title":"Metabolism-centric overview of the pathogenesis of Alzheimer\u2019s disease","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Medical Journal"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib91","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer\u2019s disease: Cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends in Neurosciences"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib92","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1194\/jlr.R088989","article-title":"Microbial impact on cholesterol and bile acid metabolism: Current status and future prospects","volume":"60","author":"Kriaa","year":"2019","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.irn.2026.05.011_bib93","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnmol.2020.00043","article-title":"Interference with complex IV as a model of age-related decline in synaptic connectivity","volume":"13","author":"Kriebel","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.011_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-9-16","article-title":"Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP\/Ld transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"Kukreja","year":"2014","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/pr.117.014092","article-title":"Anti-inflammatory effects of omega-3 fatty acids in the brain: Physiological mechanisms and relevance to pharmacology","volume":"70","author":"Lay\u00e9","year":"2018","journal-title":"Pharmacological Reviews"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib96","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/1673-5374.324824","article-title":"Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer\u2019s disease models","volume":"17","author":"Li","year":"2021","journal-title":"Neural Regeneration Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.70033","article-title":"The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system","volume":"36","author":"Li","year":"2025","journal-title":"Brain Pathology"},{"key":"10.1016\/bs.irn.2026.05.011_bib98","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2147\/CIA.S534015","article-title":"Pathological mechanisms and molecular imaging advances in Alzheimer\u2019s disease","volume":"20","author":"Liu","year":"2025","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/bs.irn.2026.05.011_bib99","article-title":"Three-dimensional interactive network: Mitochondrial-metabolic-calcium homeostasis driving Alzheimer\u2019s disease","author":"Liu","year":"2025","journal-title":"Genes & Diseases"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.irn.2026.05.011_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.634897","article-title":"Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics","volume":"8","author":"Liu","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.011_bib102","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2024.01.024","article-title":"Mechanisms of sex differences in Alzheimer\u2019s disease","volume":"112","author":"Lopez-Lee","year":"2024","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib103","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bpa.12401","article-title":"Cerebral hypoperfusion and the energy deficit in Alzheimer\u2019s disease","volume":"26","author":"Love","year":"2016","journal-title":"Brain Pathology"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.011_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108475","article-title":"Research progress on the role of oxidative stress in the pathogenesis of vascular dementia and its treatment","volume":"34","author":"Lv","year":"2025","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"28","key":"10.1016\/bs.irn.2026.05.011_bib105","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"7899","key":"10.1016\/bs.irn.2026.05.011_bib106","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.011_bib107","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-024-07152-0","article-title":"The link between amyloid \u03b2 and ferroptosis pathway in Alzheimer\u2019s disease progression","volume":"15","author":"Majern\u00edkov\u00e1","year":"2024","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.irn.2026.05.011_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119985","article-title":"Mitochondrial defects: An emerging theranostic avenue towards Alzheimer\u2019s associated dysregulations","volume":"285","author":"Mani","year":"2021","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2026.05.011_bib109","article-title":"A seven-year longitudinal study of the Alzheimer\u2019s disease blood metabolome","author":"Marella","year":"2025","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib110","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf213","article-title":"Brain [18F]FDG uptake patterns in type 2 diabetes: New phenotypes relating to biomarkers of cognitive impairment","volume":"7","author":"Mart\u00edn-Saladich","year":"2025","journal-title":"Brain Communications"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib111","article-title":"Combined 18F-FDG PET-CT markers in dementia with Lewy bodies","volume":"15","author":"Mattoli","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients","volume":"21","author":"Maurer","year":"2000","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2026.05.011_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib114","first-page":"2553","article-title":"Impairment of tricarboxylic acid cycle (TCA) cycle in Alzheimer\u2019s disease: Mechanisms, implications, and potential therapies","volume":"16","author":"Mohan","year":"2025","journal-title":"Aging and Disease"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer\u2019s disease: Methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clinical and Translational Imaging: Reviews in Nuclear Medicine and Molecular Imaging"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib116","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","volume":"29","author":"Mosconi","year":"2008","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2026.05.011_bib117","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib118","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/acn3.530","article-title":"Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer\u2019s brain","volume":"5","author":"Mullins","year":"2018","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.011_bib119","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1258\/ebm.2011.010355","article-title":"Vascular and metabolic dysfunction in Alzheimer\u2019s disease: A review","volume":"236","author":"Murray","year":"2011","journal-title":"Experimental Biology and Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4759963","article-title":"Mechanisms of mitochondrial malfunction in Alzheimer\u2019s disease: New therapeutic hope","volume":"2022","author":"Nabi","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/bs.irn.2026.05.011_bib121","article-title":"Serum amino acid levels are associated with brain metabolism in patients across the Alzheimer\u2019s disease continuum","author":"Nasiri","year":"2025","journal-title":"IBRO Neuroscience Reports"},{"key":"10.1016\/bs.irn.2026.05.011_bib122","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fphar.2020.00805","article-title":"Stimulation of GLP-1 receptor inhibits methylglyoxal-induced mitochondrial dysfunctions in H9c2 cardiomyoblasts: Potential role of Epac\/PI3K\/Akt pathway","volume":"11","author":"Nuamnaichati","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib123","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70648","article-title":"Recent advances in neuroimaging of Alzheimer\u2019s disease and related dementias","volume":"21","author":"Ottoy","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/bs.irn.2026.05.011_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: A longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.05.011_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1348410","article-title":"A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer\u2019s disease, and their co-morbidities","volume":"15","author":"Pan","year":"2024","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib126","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3390\/ijms21093369","article-title":"Autophagy in neurodegenerative diseases: A hunter for aggregates","volume":"21","author":"Park","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.011_bib127","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.freeradbiomed.2018.06.038","article-title":"Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer disease detection","volume":"124","author":"Pe\u00f1a-Bautista","year":"2018","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0005-2736(03)00024-5","article-title":"Role of cholesterol in synapse formation and function","volume":"1610","author":"Pfrieger","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.irn.2026.05.011_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.irn.2026.05.011_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106050","article-title":"The ketogenic diet as a therapeutic intervention strategy in mitochondrial disease","volume":"138","author":"Qu","year":"2021","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"25","key":"10.1016\/bs.irn.2026.05.011_bib131","article-title":"Protective ApoE variants support neuronal function by effluxing oxidized phospholipids","volume":"6273","author":"Ralhan","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2026.05.011_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105799","article-title":"Alzheimer\u2019s disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation","volume":"171","author":"Ramamoorthy","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib133","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2025.07.030","article-title":"Artificial intelligence-driven multi-omics approaches in Alzheimer\u2019s disease: Progress, challenges, and future directions","volume":"15","author":"Ren","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib134","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/antiox14010099","article-title":"Treating metabolic dysregulation and senescence by caloric restriction: Killing two birds with one stone?","volume":"14","author":"Russo","year":"2025","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-018-0354-2","article-title":"Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer\u2019s disease, whereas amyloid deposition does not","volume":"10","author":"Sang","year":"2018","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13060852","article-title":"Indoleamine 2,3-dioxygenase as a therapeutic target for Alzheimer\u2019s disease and geriatric depression","volume":"13","author":"Savonije","year":"2023","journal-title":"Brain Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib137","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","article-title":"Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance","volume":"246","author":"Sears","year":"2021","journal-title":"Experimental Biology and Medicine"},{"key":"10.1016\/bs.irn.2026.05.011_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2024.109693","article-title":"Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases","volume":"132","author":"Shahpasand","year":"2024","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib139","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease","volume":"35","author":"Simpson","year":"1994","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13024-025-00849-6","article-title":"Bridging systemic metabolic dysfunction and Alzheimer\u2019s disease: The liver interface","volume":"20","author":"Song","year":"2025","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.05.011_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.011_bib142","article-title":"Nilotinib as a prospective treatment for Alzheimer\u2019s disease: Effect on proteins involved in neurodegeneration and neuronal homeostasis","volume":"14","author":"Srivastava","year":"2024","journal-title":"Life (Chicago, Ill.: 1978)"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib143","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","article-title":"Astrocyte-neuron lactate transport is required for long-term memory formation","volume":"144","author":"Suzuki","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib144","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.011_bib145","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.3390\/ijms22158142","article-title":"Brain glucose transporters: Role in pathogenesis and potential targets for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Szablewski","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib146","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/jnc.16108","article-title":"The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology","volume":"168","author":"Tam","year":"2024","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib147","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf410","article-title":"Comprehensive metabolomics profiling reveals novel biomarkers and pathways for early detection of Alzheimer\u2019s disease","volume":"7","author":"Tiwari","year":"2025","journal-title":"Brain Communications"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib149","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s43440-022-00444-2","article-title":"Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders","volume":"75","author":"Turek","year":"2023","journal-title":"Pharmacological Reports"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib150","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/ph18050614","article-title":"Antidiabetic GLP-1 receptor agonists have neuroprotective properties in experimental animal models of Alzheimer\u2019s disease","volume":"18","author":"Urkon","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.irn.2026.05.011_bib151","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fnins.2018.00930","article-title":"Impact of metabolic syndrome on neuroinflammation and the blood\u2013brain barrier","volume":"12","author":"Van Dyken","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib152","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hest.2022.05.001","article-title":"Models of cerebral amyloid angiopathy-related intracerebral hemorrhage","volume":"3","author":"Vargas-George","year":"2022","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/bs.irn.2026.05.011_bib153","article-title":"Integrative multi-omics approaches identify molecular pathways and improve Alzheimer\u2019s disease risk prediction","author":"Venkatesh","year":"2025","journal-title":"medRxiv: The Preprint Server for Health Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.011_bib154","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.freeradbiomed.2007.12.017","article-title":"Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells","volume":"44","author":"Villena","year":"2008","journal-title":"Free Radical Biology and Medicine"},{"issue":"13","key":"10.1016\/bs.irn.2026.05.011_bib155","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.3390\/ijms22136748","article-title":"DNA damage-induced neurodegeneration in accelerated ageing and Alzheimer\u2019s disease","volume":"22","author":"Wang","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.011_bib156","article-title":"Innovations in Alzheimer\u2019s disease diagnostic technologies: Clinical prospects of novel biomarkers, multimodal integration, and non-invasive detection","volume":"16","author":"Wang","year":"2025","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.011_bib157","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/microorganisms8040527","article-title":"Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis","volume":"8","author":"Wang","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/bs.irn.2026.05.011_bib158","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.05.011_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116071","article-title":"The function of sphingolipids in different pathogenesis of Alzheimer\u2019s disease: A comprehensive review","volume":"171","author":"Wang","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"28","key":"10.1016\/bs.irn.2026.05.011_bib160","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2009","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.011_bib161","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1326-5-46","article-title":"Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model","volume":"5","author":"Wang","year":"2010","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.05.011_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00216","article-title":"Brain energy and oxygen metabolism: Emerging role in normal function and disease","volume":"11","author":"Watts","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib163","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: From molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.011_bib164","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2026.05.011_bib165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease","volume":"15","author":"Williams","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.011_bib166","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: Unraveling the potential for Alzheimer\u2019s disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Delivery and Translational Research"},{"issue":"17","key":"10.1016\/bs.irn.2026.05.011_bib167","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.3390\/ijms241713398","article-title":"Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases","volume":"24","author":"Wu","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.011_bib168","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-025-03490-8","article-title":"Cholesterol in the CNS: Functions, recycling and remyelination","volume":"22","author":"Wuerch","year":"2025","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.irn.2026.05.011_bib169","article-title":"High-throughput metabolomics for discovering potential biomarkers and identifying metabolic mechanisms in aging and Alzheimer\u2019s disease","volume":"9","author":"Xie","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/bs.irn.2026.05.011_bib170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: Pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.011_bib171","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuint.2006.03.007","article-title":"Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes","volume":"49","author":"Xiu","year":"2006","journal-title":"Neurochemistry International"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.011_bib172","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-016-0361-4","article-title":"Apolipoprotein E as a therapeutic target in Alzheimer\u2019s disease: A review of basic research and clinical evidence","volume":"30","author":"Yamazaki","year":"2016","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.011_bib173","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.011_bib174","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/biomedicines9111587","article-title":"Mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in Alzheimer\u2019s disease","volume":"9","author":"Yao","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib175","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/alz.12845","article-title":"Nutritional metabolism and cerebral bioenergetics in Alzheimer\u2019s disease and related dementias","volume":"19","author":"Yassine","year":"2023","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"key":"10.1016\/bs.irn.2026.05.011_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102952","article-title":"Decoding blood-brain barrier dysfunction in Alzheimer\u2019s disease: Innovations and challenges in multimodal MRI and PET imaging biomarkers","volume":"114","author":"Yin","year":"2026","journal-title":"Ageing Research Reviews"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.011_bib177","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"Ketone body \u03b2-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nature Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2026.05.011_bib178","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/brainsci13101459","article-title":"Alteration of metabolic profiles during the progression of Alzheimer\u2019s disease","volume":"13","author":"Yu","year":"2023","journal-title":"Brain Sciences"},{"key":"10.1016\/bs.irn.2026.05.011_bib179","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40035-022-00305-1","article-title":"Defective mitophagy and the etiopathogenesis of Alzheimer\u2019s disease","volume":"11","author":"Zeng","year":"2022","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.irn.2026.05.011_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102089","article-title":"Glucose metabolic crosstalk and regulation in brain function and diseases","volume":"204","author":"Zhang","year":"2021","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib182","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"41","key":"10.1016\/bs.irn.2026.05.011_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503645","article-title":"Targeting multilayered metabolic networks in brain diseases: Emerging perspectives on nanodelivery strategies","volume":"12","author":"Zhou","year":"2025","journal-title":"Advanced Science"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib184","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","article-title":"Ketogenic diet for human diseases: The underlying mechanisms and potential for clinical implementations","volume":"7","author":"Zhu","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"0 1","key":"10.1016\/bs.irn.2026.05.011_bib185","first-page":"S253","article-title":"Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer\u2019s disease","volume":"33","author":"Zhu","year":"2013","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.011_bib186","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: Mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:18:35Z","timestamp":1785874715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":186,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.05.011","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}